profile

Andy Hsieh

Research Analyst

About Dr. Hsieh

Andy Hsieh, Ph.D., a biotechnology analyst, joined William Blair in January 2014, after an internship as a research associate with Cowen & Company. Dr. Hsieh earned a Ph.D. in chemistry from the University of California, Berkeley and a B.S. in biological sciences from Carnegie Mellon University.

Coverage List

TICKER COMPANY
ATNM Actinium Pharmaceuticals, Inc.
ARAV Aravive, Inc.
BYSI BeyondSpring Inc.
EXEL Exelixis Inc.
FGEN FibroGen, Inc.
IMGN ImmunoGen, Inc.
NKTR Nektar Therapeutics
SGEN Seagen Inc.
VKTX Viking Therapeutics, Inc.